telmisartan has been researched along with Glomerulosclerosis, Focal Segmental in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, E; Asanuma, K; Asao, R; Jeong, KH; Kodama, F; Lydia, A; Takagi, M; Tomino, Y | 1 |
| He, Y; Huang, Q; Jiang, J; Li, M; Liu, X; Ma, D; Wang, S; Xu, G; Yao, Y; Zhou, J; Zou, R | 1 |
2 other study(ies) available for telmisartan and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Benzoates; Calcitriol; Doxorubicin; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Membrane Proteins; Mice; Mice, Inbred BALB C; Podocytes; Telmisartan | 2015 |
Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Extracellular Matrix; Glomerulosclerosis, Focal Segmental; Mesangial Cells; PPAR gamma; Rats; Telmisartan; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2008 |